Biological Evaluation and Structural Determinants of p38α Mitogen-Activated-Protein Kinase and c-Jun-N-Terminal Kinase 3 Inhibition by Flavonoids

被引:36
作者
Goettert, Marcia [1 ]
Schattel, Verena [1 ]
Koch, Pierre [1 ]
Merfort, Irmgard [2 ]
Laufer, Stefan [1 ]
机构
[1] Univ Tubingen, Inst Pharm, Dept Pharmaceut & Med Chem, D-72076 Tubingen, Germany
[2] Univ Freiburg, Dept Pharmaceut Biol & Biotechnol, D-79104 Freiburg, Germany
关键词
flavonoids; JNK3; molecular modeling; p38alpha MAP kinase; structure-activity relationships; P38 MAP KINASE; PLANT FLAVONOIDS; CANCER-TREATMENT; JNK3; ASSAY; IMMUNOSORBENT; OPTIMIZATION; SELECTIVITY; PATHWAYS; LUTEOLIN;
D O I
10.1002/cbic.201000487
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of 42 naturally occurring flavonoids and one flavonoid glucuronide were tested for their ability to inhibit p38 alpha mitogen-activated protein kinase (p38 alpha) and c-Jun-N-terminal kinase 3 (JNK3). Potent inhibitors with IC50 values in the low micromolar range were identified. Structure-activity relationships were evaluated and the most promising compounds were docked into the ATP binding site of these kinases. Among the different classes of flavonoids, the flavonol group showed better inhibition of p38a. Of this class, kaempferol-7,4'-dimethylether was a potent p38 alpha inhibitor, displaying 13-fold selectivity for p38 alpha over JNK3. The flavone compounds without a 6-methoxy group preferentially inhibited JNK3. The flavone glycoside, luteolin-7-O-glycoside, was identified as a potent inhibitor with the greatest selectivity toward JNK3. In contrast, the flavanol compounds displayed similar inhibitory activities toward both kinases.
引用
收藏
页码:2579 / 2588
页数:10
相关论文
共 33 条
[1]  
[Anonymous], 2002, PYMOL MOL GRAPHICS S
[2]   HOW MAP KINASES ARE REGULATED [J].
COBB, MH ;
GOLDSMITH, EJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (25) :14843-14846
[3]   PROTEIN-KINASE C INHIBITION BY PLANT FLAVONOIDS - KINETIC MECHANISMS AND STRUCTURE-ACTIVITY-RELATIONSHIPS [J].
FERRIOLA, PC ;
CODY, V ;
MIDDLETON, E .
BIOCHEMICAL PHARMACOLOGY, 1989, 38 (10) :1617-1624
[4]   Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease [J].
Garcia-Lafuente, Ana ;
Guillamon, Eva ;
Villares, Ana ;
Rostagno, Mauricio A. ;
Alfredo Martinez, Jose .
INFLAMMATION RESEARCH, 2009, 58 (09) :537-552
[5]   Optimization of a nonradioactive immunosorbent assay for p38α mitogen-activated protein kinase activity [J].
Goettert, Marcia ;
Graeser, Ralph ;
Laufer, Stefan A. .
ANALYTICAL BIOCHEMISTRY, 2010, 406 (02) :233-234
[6]  
HAGIWARA M, 1988, BIOCHEM PHARMACOL, V37, P2987
[7]   Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases [J].
Johnson, GL ;
Lapadat, R .
SCIENCE, 2002, 298 (5600) :1911-1912
[8]   Structure-Activity Relationships and X-ray Structures Describing the Selectivity of Aminopyrazole Inhibitors for c-Jun N-terminal Kinase 3 (JNK3) over p38 [J].
Kamenecka, Ted ;
Habel, Jeff ;
Duckett, Derek ;
Chen, Weimin ;
Ling, Yuan Yuan ;
Frackowiak, Bozena ;
Jiang, Rong ;
Shin, Youseung ;
Song, Xinyi ;
LoGrasso, Philip .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (19) :12853-12861
[9]  
KUBINYI H, 2004, CHEMOGENOMICS DRUG D, P463
[10]   An immunosorbent, nonradioactive p38 MAP kinase assay comparable to standard radioactive liquid-phase assays [J].
Laufer, S ;
Thuma, S ;
Peifer, C ;
Greim, C ;
Herweh, Y ;
Albrecht, A ;
Dehner, F .
ANALYTICAL BIOCHEMISTRY, 2005, 344 (01) :135-137